Articles by James Calloway
Invenergy Accepts $765M Payout to Exit Offshore Wind Leases
Invenergy will get $765 million to terminate four offshore wind leases, with funds redirected to natural gas and geothermal, as the administration's buyback program nears $2.6 billion.
U.S. DOT Closes Delta Probe Without Penalties, Easing Regulatory Pressure
The DOT closed its probe into Delta's 2024 CrowdStrike outage without penalties, removing a major regulatory risk for the airline.
Coupang Stock Jumps on $410M Privacy Fine Disclosure, Analyst Upgrade
Coupang shares surged 8.3% to $19.53 after disclosing $410 million in Korean privacy fines and receiving an Outperform rating from CLSA with a $24 target.
Micron Stock Surges as Analysts Boost Price Targets on AI Memory Demand
Micron shares jumped 3.3% to $1,054.62, lifting market cap near $1.20 trillion, as analysts hiked targets to $1,500 on strong AI memory demand ahead of June 24 earnings.
Boeing 737 MAX 7 and MAX 10 Near Final Regulatory Clearance
Boeing's 737 MAX 7 and MAX 10 are in the final stage of U.S. and European regulatory approval, with only documentation left. Certification is crucial for Boeing's cash recovery and airline customers.
FDA Greenlights uniQure's Accelerated Approval Path for Huntington's Gene Therapy
uniQure shares surged 78% premarket after the FDA agreed to accept three-year Phase I/II data as the basis for an accelerated approval filing for AMT-130 in Huntington's disease, reviving the near-term U.S. path for the potential first disease-modifying treatment.
CarMax Revenue Beat Fails to Ease Margin Concerns
CarMax beat Q1 revenue estimates at $8.01B, but retail gross profit per unit dropped to $2,177, highlighting ongoing margin pressure. Shares rose 5% premarket before settling near $52.11.
La-Z-Boy Surges on Q4 Earnings Beat, $300M Buyback
La-Z-Boy shares surged nearly 17% after hours after Q4 adjusted earnings of $1.26 per share beat estimates, offsetting a 7.2% drop in regular trading, as retail expansion and a $300 million buyback boosted sentiment.
Pfizer Shares Edge Up as Rigel Completes Veppanu Licensing Deal
Pfizer shares edged up after Rigel completed a Veppanu licensing deal with Arvinas, providing a $35 million payment to Pfizer.
AT&T Stock Hovers Near 52-Week Low Amid Debt and Dividend Concerns
AT&T shares fell 1.5% to $22.95, approaching a 52-week low, as the market weighs debt, capital spending, and competitive pressures ahead of Q2 earnings on July 22.
Ford Stock Dips on China Software Rule Uncertainty
Ford shares slipped 1.1% to $14.61 after Reuters reported the company needs U.S. approval to keep importing China-built Lincoln Nautilus SUVs due to new connected-vehicle rules.